Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications

References

• Ruol A, Parenti A, Zaninotto G, Mergliano S, Costantini M, Cagol M, Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000;88:2520–8.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:927–33.
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249–56.
   PubMed Web of Science ®Google Scholar
• Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. Br Med J 2003;327:534–5.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857–9.
   PubMed Web of Science ®Google Scholar
• Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1996;92:212–5.
   Google Scholar
• Anderson LA, Watson RGP, Murphy SJ, Johnston BJ, Comber H, Mc Guigan J, Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007;13:1585–94.
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340(11):825–31.
   PubMedGoogle Scholar
• Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402–7.
   PubMed Web of Science ®Google Scholar
• Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645–54.
   PubMed Web of Science ®Google Scholar
• Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992;1:265–9.
   PubMedGoogle Scholar
• Moller H. Incidence of cancer of oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev 1992;1:159–64.
   PubMedGoogle Scholar
• Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26(Suppl 15):2–8.
   PubMedGoogle Scholar
• Chang JT, Katzka DA. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma. Arch Intern Med 2004;164:1482–8.
   PubMedGoogle Scholar
• Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;20;100(16):1184–7.
   PubMedGoogle Scholar
• Kikendall JW, Mellow MH. Effect of sublingual nitroglycerin and long-acting nitrate preparations on esophageal motility. Gastroenterology 1980;79:703–706.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Iwakiri K, Sugiura T, Kobayashi M. Effect of nifedipine administration (10 mg) on esophageal acid exposure time. J Gastroenterol 2000;35:43–6.
   PubMed Web of Science ®Google Scholar
• Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001;120:1184–9.
   PubMed Web of Science ®Google Scholar
• Rushnak MJ, Leevy CM. Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study. Am J Gastroenterol 1980;73:127–30.
   PubMed Web of Science ®Google Scholar
• Corley DA, Levin TR, Habel LA, Buffler PA. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol 2006;101:937–44.
   PubMedGoogle Scholar
• Vaughan TL Farrow DC, Hansten PD, Chow WH, Gammon MD, Risch HA, Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastroesophageal reflux. Cancer Epidemiol Biomark Prev 1998;7:749–56.
   PubMedGoogle Scholar
• Lagergren J, Bergstrom R, Adami HO, Nyren O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000;133:165–75.
   PubMed Web of Science ®Google Scholar
• Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol 2007;5:1154–9.
   PubMed Web of Science ®Google Scholar
• Anderson LA, Johnston BT, Watson GRP, Murphy SJ, Ferguson HR, Comber H, Nonsteroidal anti-inflammatory drugs and the esophageal inflammation–metaplasia–adenocarcinoma sequence. Cancer Res 2006;66:4975–82.
   PubMedGoogle Scholar
• Sontag SJ, Harding SM. Gastroesophageal reflux and asthma. In: Goyal RK, Shaker R, editors. Goyal and Shaker's GI Motility Online. Nature Publishing Group, New York; 2006.
   Google Scholar
• Simpson WG. Gastroesophageal reflux disease and asthma. Diagnosis and management. Arch Intern Med 1995;155:798–803.
   PubMedGoogle Scholar
• Harding SM. Recent clinical investigations examining the association of asthma and gastroesophageal reflux. Am J Med 2003;115(Suppl 3A):39S–44S.
   Google Scholar
• Tuchman DN, Boyle JT, Pack AI, Scwartz J, Kokonos M, Spitzer AR, Cohen S. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984;87:872–81.
   PubMed Web of Science ®Google Scholar
• Sant'Ambrogio FB, Sant'Ambrogio G, Chung K. Effects of HCl-pepsin laryngeal instillations on upper airway patency-maintaining mechanisms. J Appl Physiol 1998;84:1299–304.
   PubMedGoogle Scholar
• Ricciardolo FL, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, Geppetti P. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med 1999;159:557–62.
   PubMed Web of Science ®Google Scholar
• Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 1995;50:201–4.
   PubMed Web of Science ®Google Scholar
• Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy 1978;41:224–6.
   PubMedGoogle Scholar
• Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the nord-trondelag health survey. Chest 2006;129:1051–6.
   PubMed Web of Science ®Google Scholar
• Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990;99:613–20.
   PubMed Web of Science ®Google Scholar
• Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996;100:395–405.
   PubMed Web of Science ®Google Scholar
• Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterol Motil 2005;17(S1):13–21.
   PubMedGoogle Scholar
• Newton M, Burnham WR, Kamm M. Morbidity, mortality and risk factors for esophagitis in hospital inpatients. J Clin Gastroenterol 2000;30:264–9.
   PubMedGoogle Scholar
• Labenz J, Jaspersen D, Kulig M, Leodolter A. Lind T, Meyer-Sabellek W, et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 2004;99:1652–6.
   PubMed Web of Science ®Google Scholar